Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
100942614 | 10094261 | 4 | F | 20160823 | 20140422 | 20160830 | EXP | BR-ROCHE-1347162 | ROCHE | 0.00 | F | Y | 70.00000 | KG | 20160830 | CN | BR | BR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
100942614 | 10094261 | 1 | PS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | 1 DF, QMO | U | 103976 | 1 | DF | SOLUTION FOR INJECTION | /month | |||||
100942614 | 10094261 | 2 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | 150 MG, QMO | U | 103976 | 150 | MG | SOLUTION FOR INJECTION | /month | |||||
100942614 | 10094261 | 3 | C | CAPTOPRIL. | CAPTOPRIL | 1 | Unknown | UNK (STARTED 5 YEARS AGO) | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
100942614 | 10094261 | 1 | Asthma |
100942614 | 10094261 | 3 | Hypertension |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
100942614 | 10094261 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
100942614 | 10094261 | Asthmatic crisis | |
100942614 | 10094261 | Blood pressure increased | |
100942614 | 10094261 | Breath sounds abnormal | |
100942614 | 10094261 | Diabetes mellitus | |
100942614 | 10094261 | Visual impairment | |
100942614 | 10094261 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |